Anti-Factor H Antibody–Associated and Complement–Mediated Atypical Hemolytic Uremic Syndrome With Homozygous Cfhr1-Cfhr3 Deletion: A Case Report

The human body possesses a sophisticated internal defense system known as the immune system, designed to identify and neutralize foreign invaders like bacteria and viruses. Within this system lies a specialized network called the complement system, a group of proteins that circulate in the blood ready to spring into action. Their job is to patrol the bloodstream, tagging harmful cells for destruction and helping to clear away debris. However, this powerful force must be kept in strict check; if it becomes overactive, it can begin to attack the body's own healthy tissues, particularly the tiny blood vessels in the kidneys. When this regulation fails, a rare and dangerous condition can develop where blood clots form in these microscopic vessels, destroying red blood cells and causing the kidneys to shut down. This scenario is known as atypical hemolytic uremic syndrome, a life-threatening emergency that requires precise diagnosis to distinguish it from other causes of kidney failure.

In a recent case report from India, medical researchers documented the journey of a ten-year-old girl who arrived at the hospital with a severe and sudden illness. She had no history of diarrhea, which is a common trigger for a more typical form of kidney failure, but instead presented with fever, vomiting, and a rapid decline in her health. Her blood tests revealed a terrifying combination of symptoms: her red blood cells were being shredded, her platelet count was dangerously low, and her kidneys were struggling to filter waste. The medical team suspected a breakdown in the body's internal safety mechanisms, but the specific cause remained hidden until they looked deeper into her immune system and genetic makeup.

The investigation began by ruling out the usual suspects. Tests for bacterial toxins and autoimmune diseases came back negative, and the girl's blood showed no signs of the specific enzyme deficiency that causes a different blood disorder. Instead, the focus shifted to the complement system, the very network responsible for regulating blood vessel health. While the levels of the main complement proteins in her blood appeared normal, a specialized test revealed a massive spike in a specific antibody. This antibody was attacking factor H, a crucial protein that normally acts as a brake on the complement system to prevent it from damaging the body. Without this brake, the complement system was running wild, causing the blood clots and kidney injury.

To understand why this girl's body had produced such a destructive antibody, the researchers examined her DNA. They discovered that she possessed a specific genetic deletion, meaning she was missing two genes entirely on both copies of her chromosomes. These genes, which code for proteins related to the immune system, are usually present in healthy individuals. Their absence is known to confuse the immune system, making it difficult to tell the difference between the body's own proteins and foreign threats. This genetic gap likely caused her immune system to mistakenly view factor H as an enemy, leading to the production of the high levels of antibodies that triggered the crisis.

The treatment plan relied on removing the harmful antibodies from her blood and replacing them with healthy ones. The medical team performed therapeutic plasma exchange, a procedure where the patient's blood is filtered to remove the plasma containing the attacking antibodies and replaced with fresh donor plasma. This process was repeated five times. Alongside this, the girl received corticosteroids, a type of medication that calms the immune system and stops it from producing more antibodies. Because a newer, highly targeted drug that blocks the complement system directly was not available at their facility, the team relied on this established combination of blood filtering and immune suppression.

The results were striking. Within days, the girl's blood counts began to recover. Her platelets, which had dropped to a critical low, rose back to a healthy level, and her red blood cells stopped being destroyed. Her kidney function improved dramatically, with her waste filtration levels returning to normal. By the time she was discharged, her blood pressure was controlled, and she was free from the immediate threat of organ failure. She continued to take medication to keep her immune system in check, and at her latest follow-up, she remained stable with no signs of the disease returning.

This case serves as a vital reminder that even when standard blood tests appear normal, a rare genetic and immune disorder can still be the cause of severe illness. The researchers demonstrated that combining a careful look at the patient's symptoms with advanced genetic testing and specific antibody measurements can unlock the correct diagnosis. For this young girl, that precise understanding allowed her doctors to choose the right treatment, turning a potentially fatal outcome into a full recovery. It highlights that in the complex landscape of human health, the key to saving a life often lies in connecting the dots between a patient's genes, their immune response, and the specific tools available to treat them.